Tenon Medical, Inc.
For the period ended May 12, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 12, 2026 · Filed May 12, 2026
Use the contents to explore the available documents and sections.
TNON$1.640.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (In thousands, except per share data)
(In thousands, except per share data)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Revenue | $1,379 | $726 |
| Cost of revenue | 434 | 403 |
| Gross Profit | 945 | 323 |
| Operating Expenses | ||
| Research and development | 662 | 691 |
| Sales and marketing | 1,858 | 1,647 |
| General and administrative | 1,705 | 1,662 |
| Total Operating Expenses | 4,225 | 4,000 |
| Loss from Operations | (3,280) | (3,677) |
| Other (Expense) Income, net | ||
| Gain on investments | 25 | 61 |
| Interest expense | (176) | — |
| Other expense | (45) | — |
| Total Other (Expense) Income, net | (196) | 61 |
| Net Loss | $(3,476) | $(3,616) |
| Net Loss Per Share of Common Stock | ||
| Basic and diluted | $(0.31) | $(1.01) |
| Weighted Average Shares of Common Stock Outstanding | ||
| Basic and diluted | 11,268 | 3,597 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.